Andes Technology Unveils the Annual Andes RISC-V CON, Scheduled for June 27th at the San Jose Airport DoubleTree Hotel
26 juin 2023 17h30 HE
|
Andes Technology Corporation
San Jose, June 26, 2023 (GLOBE NEWSWIRE) -- Andes Technology Corporation (TWSE: 6533; SIN: US03420C2089; ISIN: US03420C1099), a leading supplier of high efficiency, low-power 32/64-bit RISC-V...
An Urgent Ask During #GIVINGTUESDAY for Our Police Who Suffer From PTSD
03 déc. 2019 07h00 HE
|
TTM PTP, Inc.
NEW YORK, Dec. 03, 2019 (GLOBE NEWSWIRE) -- EndPTSD 's TTMPT.Org is launching their first #GivingTuesday Campaign to Raise Funds and Awareness for Officers Across the US Suffering From Post...
Witnet Completes Development of Mobilick for Microsoft Windows CE.Net
14 avr. 2003 09h28 HE
|
Witnet International, Inc.
TORONTO, April 14, 2003 (PRIMEZONE) -- Witnet International, Inc. (OTCBB:WTNT) announced today that it has completed development of the CE.Net version of its mobile remote access software...
Actelion Presents a Full and Promising Clinical Pipeline -- Strong R&D as Basis for Above-industry Growth
04 mars 2003 01h50 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, March 4, 2003 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) (Other OTC:ALIOF) today provided a complete overview of its clinical pipeline at its annual Analyst and Media Day....
Astex Announces Alzheimer's Drug Discovery Collaboration with AstraZeneca
03 mars 2003 03h14 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., March 3, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced a collaboration with AstraZeneca. The agreement relates to the discovery of...
Crucell Signs PER.C6 License with Targeted Genetics
14 févr. 2003 03h01 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Feb. 14, 2003 (PRIMEZONE) -- Crucell N.V. (Nasdaq:CRXL) announced today that it has signed a non-exclusive PER.C6(TM) license agreement with Seattle-based Targeted Genetics...
Actelion 2002 Operating Revenues at CHF 140.3 Million
23 janv. 2003 02h29 HE
|
Actelion Ltd.
ALLSCHWIL and BASEL, Switzerland, Jan. 23, 2003 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) (Other OTC:ALIOF) today reported operating revenues for the year 2002 of CHF 140.3 million (2001: 64.1...
20-Minute Professor is Offering its New and Effective High-Speed Homework Software FREE to Parents of School-Aged Children
30 déc. 2002 16h05 HE
|
20-Minute Professor
FLOURTOWN, Pa., Dec. 30, 2002 (PRIMEZONE) -- Fred Catona, former award-winning teacher and President of 20-Minute Professor.Com, announced today that his company is making its new Homework Software...
Centocor Returns Rights to Anti-CD46 Antibody to Crucell
24 déc. 2002 02h40 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Dec. 24, 2002 (PRIMEZONE) -- Dutch antibody and vaccine company, Crucell N.V. (Nasdaq:CRXL) today announced that Centocor and Crucell have agreed not to advance the...
Cambridge Antibody Technology and Crucell Settle Patent Dispute
20 déc. 2002 02h33 HE
|
Crucell N.V.
MELBOURN, U.K. and LEIDEN, The Netherlands, Dec. 20, 2002 (PRIMEZONE) -- Cambridge Antibody Technology (LSE:CAT) (Nasdaq:CATG) and Crucell N.V. (Nasdaq: CRXL) today announced that they have agreed on...